Objective:

To commend the DEA's initiative to temporarily schedule certain kratom-related substances due to public safety concerns.

Approach:

• DEA Notices of Intent: The DEA issued two Notices of Intent to temporarily schedule 7-OH and three synthetic derivatives (MP, MGM-15, MGM-16) in Schedule I.
• Request for Information: The Office of the Assistant Secretary for Health (OASH) requested public comments on the proposed threshold level for 7-OH.

Key Findings:

• 7-OH and its synthetic derivatives are considered dangerous opioids that contribute to addiction.
• The actions do not intend to regulate natural kratom leaf that contains trace amounts of 7-OH.
• MP, MGM-15, and MGM-16 are synthetic derivatives that do not occur naturally in the kratom plant.
• MP is a chemical rearrangement product of 7-OH, while MGM-15 and MGM-16 are synthetic derivatives of 7-OH.

Interpretation:

The scheduling of these substances aims to address the growing threat they pose to public health and safety.

Limitations:

• The temporary scheduling order is subject to public comment and further review by the Attorney General.

Conclusion:

The initiative is part of a broader effort to combat the opioid epidemic and protect public health.

Sources:

• HHS Press Release